Therefore, inhibiting NFIL3 reduces the expression of genes related to lipid droplet association and fat uptake in hepatocytes, decelerates de novo lipogenesis, and alleviates HFD-induced hepatic steatosis and liver injury (Yang et al., 2020; Matsumura et al., 2021). This evidence concerns the gene NFIL3 and Hepatic steatosis.